Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques

NCT06855537 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

2190

Enrollment

OTHER

Sponsor class

Conditions

Coronary Arterial Disease (CAD)
Vulnerable Coronary Plaques
Thin-cap fIbroatheroma
Acute Coronary Syndromes (ACS)

Interventions

PROCEDURE: PCI strategy
DRUG: OMT strategy

Sponsor

Beijing Anzhen Hospital